|
CNOT6L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00640000003194E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.44769999999017E-06 |
| Normal-vs-Stage2 |
1.092360E-02 |
| Normal-vs-Stage3 |
3.341400E-03 |
| Normal-vs-Stage4 |
1.156160E-04 |
| Stage1-vs-Stage2 |
7.673000E-01 |
| Stage1-vs-Stage3 |
6.846400E-01 |
| Stage1-vs-Stage4 |
2.558200E-01 |
| Stage2-vs-Stage3 |
6.401800E-01 |
| Stage2-vs-Stage4 |
2.473400E-01 |
| Stage3-vs-Stage4 |
5.274000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.72530000000604E-06 |
| Normal-vs-AfricanAmerican |
7.96280000000538E-05 |
| Normal-vs-Asian |
2.81059999995836E-06 |
| Caucasian-vs-AfricanAmerican |
7.367600E-01 |
| Caucasian-vs-Asian |
4.359900E-03 |
| AfricanAmerican-vs-Asian |
5.379800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.63130000002876E-06 |
| Normal-vs-Female |
7.92490000000035E-05 |
| Male-vs-Female |
8.901600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.25689999996847E-06 |
| Normal-vs-Extreme_Weight |
1.92509999996648E-06 |
| Normal-vs-Obese |
1.355590E-02 |
| Normal-vs-Extreme_Obese |
3.988100E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.721000E-01 |
| Normal_Weight-vs-Obese |
2.422500E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.031600E-01 |
| Extreme_Weight-vs-Obese |
6.119800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.020200E-01 |
| Obese-vs-Extreme_Obese |
1.637180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.736400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.804260E-03 |
| Normal-vs-Age(61-80Yrs) |
4.02609999783365E-08 |
| Normal-vs-Age(81-100Yrs) |
6.20969999999277E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.694400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.464000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.096400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.036280E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.147640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.968800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.159520E-04 |
| Normal-VS-Type2 PRCC |
2.39940000090755E-08 |
| Normal-VS-KIRP CIMP |
1.688170E-01 |
| Normal-VS-Unclassified PRCC |
1.018200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.163260E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.696800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.412000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.017400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.876440E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.696200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.44730002929572E-09 |
| Normal-vs-N1 |
4.716600E-03 |
| Normal-vs-N2 |
4.344000E-02 |
| N0-vs-N1 |
3.014200E-01 |
| N0-vs-N2 |
4.930000E-01 |
| N1-vs-N2 |
9.913000E-01 |
|
|
